- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 519/06 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or containing at least one condensed beta-lactam ring system, provided for by groups , or , e.g. a penem or a cepham system
Patent holdings for IPC class C07D 519/06
Total number of patents in this class: 25
10-year publication summary
|
2
|
2
|
0
|
1
|
1
|
1
|
1
|
2
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shionogi & Co., Ltd. | 873 |
9 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 376 |
2 |
| Shanghai Hansoh Biomedical Co., Ltd. | 355 |
2 |
| Merck Sharp & Dohme LLC | 3735 |
2 |
| Novartis AG | 10263 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| Nanyang Technological University | 2200 |
1 |
| Orchid Chemicals & Pharmaceuticals Limited | 34 |
1 |
| Promega Corporation | 589 |
1 |
| Shenzhen Haibin Pharmaceutical Co., Ltd. | 14 |
1 |
| Tennor Therapeutics (Suzhou) Limited | 30 |
1 |
| Xinxiang Haibin Pharmaceutical Co., Ltd. | 5 |
1 |
| Joincare Haibin Pharmaceutical Co., Ltd. | 2 |
1 |
| Beijing Earthwise Technology Co., Ltd. | 12 |
1 |
| Other owners | 0 |